Efraín Garrido Selected Research

Astemizole

1/2020	Eag1 Gene and Protein Expression in Human Retinoblastoma Tumors and its Regulation by pRb in HeLa Cells.
12/2017	Astemizole inhibits cell proliferation in human prostate tumorigenic cells expressing ether à-go-go-1 potassium channels.
1/2017	The combination astemizole-gefitinib as a potential therapy for human lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Efraín Garrido Research Topics

Disease

3	Neoplasms (Cancer) 01/2020 - 01/2017
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 08/2020
1	Retinoblastoma (Glioblastoma, Retinal) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Leukemia 01/2017
1	Infections 05/2016
1	Inflammation (Inflammations) 05/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 08/2020 - 01/2017
3	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2020 - 01/2017
3	Histamine Receptors (Histamine Receptor)IBA 01/2020 - 01/2017
3	AstemizoleIBA 01/2020 - 01/2017
2	Ether (Diethyl Ether)IBA 01/2020 - 12/2017
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
2	Histamine Antagonists (Antihistamines)IBA 01/2020 - 01/2017
2	Potassium Channels (Potassium Channel)IBA 12/2017 - 01/2017
1	emerinIBA 08/2020
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 12/2017
1	5-Methylcytosine (5 Methylcytosine)IBA 10/2017
1	Biological ProductsIBA 10/2017
1	EnzymesIBA 10/2017
1	5-hydroxymethylcytosineIBA 10/2017
1	Gefitinib (Iressa)FDA Link 01/2017
1	Annexin A2 (Annexin II)IBA 05/2016
1	ChemokinesIBA 05/2011
1	CytokinesIBA 05/2011

Therapy/Procedure

2	Therapeutics 10/2017 - 01/2017